Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
7.18
|
7.03
|
7.36
|
7.25
|
|
|
130 155.38
|
186.00
|
|
9.13
|
7.40
|
7.16
|
7.40
|
7.16
|
|
|
138 706.05
|
131.00
|
|
|
7.54
|
7.31
|
7.54
|
7.49
|
|
|
84 091.43
|
224.00
|
7.31
|
7.86
|
7.38
|
7.25
|
7.63
|
7.53
|
|
|
33 952.92
|
117.00
|
7.19
|
7.73
|
7.31
|
7.15
|
7.41
|
7.18
|
|
|
139 587.58
|
125.00
|
|
|
7.64
|
7.33
|
7.64
|
7.33
|
|
|
50 587.92
|
113.00
|
|
9.39
|
7.45
|
7.38
|
7.565
|
7.53
|
|
|
39 570.90
|
189.00
|
|
|
7.45
|
7.35
|
7.46
|
7.39
|
|
|
30 215.46
|
152.00
|
|
|
7.70
|
7.49
|
7.70
|
7.49
|
|
|
79 405.80
|
183.00
|
|
|
7.91
|
7.67
|
7.91
|
7.70
|
|
|
30 274.68
|
114.00
|
Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.